“A home-based testing tool will enable patients to monitor their lithium blood concentrations daily and adjust their medication accordingly,” said Kent Henry, Ph.D., ADA senior scientist and principal investigator on the project. “Just as home monitoring of blood sugar levels enables diabetics to manage their health, individuals with bipolar disorder will be better equipped to manage their health and overall well-being.”
ADA is a research, development, and commercialization company that engage in creating and converting innovative technologies to commercial successes.
